11 – 20 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Fetal safety of erythromycin. An update of Swedish data.
(
- Contribution to journal › Article
-
Mark
Risk of neurodisability and other long-term outcomes for infants born following assisted reproductive technologies.
(
- Contribution to journal › Scientific review
-
Mark
Use of ondansetron during pregnancy and congenital malformations in the infant.
(
- Contribution to journal › Article
-
Mark
Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring.
(
- Contribution to journal › Article
- 2013
-
Mark
Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
(
- Contribution to journal › Article
-
Mark
The Use of Central Nervous System Active Drugs During Pregnancy.
(
- Contribution to journal › Article
-
Mark
The term ''asthma" should be avoided in describing the chronic pulmonary disease of prematurity
(
- Contribution to journal › Letter
-
Mark
Association between preterm birth and intrauterine growth retardation and child asthma.
(
- Contribution to journal › Article
-
Mark
Maternal and fetal factors which affect fetometry: use of in vitro fertilization and birth register data.
(
- Contribution to journal › Article
-
Mark
Maternal drug use during pregnancy and asthma risk among children.
2013) In Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 24(1). p.28-32(
- Contribution to journal › Article